The Obstetric Fistula Complex; Classification
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
NUR 306- MIDWIWERY-II.Pdf
THE CATHOLIC UNIVERSITY OF EASTERN AFRICA P.O. Box 62157 A. M. E. C. E. A 00200 Nairobi - KENYA Telephone: 891601-6 Fax: 254-20-891084 MAIN EXAMINATION E-mail:[email protected] SEPTEMBER-DECEMBER 2020 TRIMESTER SCHOOL OF NURSING REGULAR PROGRAMME NUR/UNUR 306: MIDWIFERY II-LABOUR Date: DECEMBER2020 Duration: 3 Hours INSTRUCTIONS: i. All questions are compulsory ii. Indicate the answers in the answer booklet provided PART -I: MULTIPLE CHOICE QUESTIONS (MCQs) (20 MARKS): Q1.The following are two emergencies that can occur in third stage of labour: a) Cord prolapsed, foetal distress. b) Ruptured uterus ,foetal distress. c) Uterine inversion, cord pulled off. d) Cord round the neck, foetal distress. Q2 A woman in preterm labor at 30 weeks of gestation receives two 12-mg doses of betamethasone intramuscularly. The purpose of this pharmacologic treatment is to: a). Stimulate fetal surfactant production. b). Reduce maternal and fetal tachycardia associated with ritodrine administration. c). Suppress uterine contractions. d). Maintain adequate maternal respiratory effort and ventilation during magnesium sulfate therapy. Q3. Episiotomy should only be considered in case of : a) Breech, vacuum delivery, scarring from genital cutting, fetal distress. b) Primigravida, disturbed woman, genital cutting, obstructed labor. c) Obstructed labor, hypertonic contractions, multigravida, forceps delivery. Cuea/ACD/EXM/APRIL 2020/SCHOOL OF NURSING Page 1 ISO 9001:2015 Certified by the Kenya Bureau of Standards d) Primigravida, hypotonic contractions, fetal distress, genital cutting. Q4.A multiporous woman in labour tells the midwife “I feel like opening the bowels”.How should the midwife respond? a) Allow the woman to use the bedpan. -
Delivery Mode for Prolonged, Obstructed Labour Resulting in Obstetric Fistula: a Etrr Ospective Review of 4396 Women in East and Central Africa
View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by eCommons@AKU eCommons@AKU Obstetrics and Gynaecology, East Africa Medical College, East Africa 12-17-2019 Delivery mode for prolonged, obstructed labour resulting in obstetric fistula: a etrr ospective review of 4396 women in East and Central Africa C. J. Ngongo T. J. Raassen L. Lombard J van Roosmalen S. Weyers See next page for additional authors Follow this and additional works at: https://ecommons.aku.edu/eastafrica_fhs_mc_obstet_gynaecol Part of the Obstetrics and Gynecology Commons Authors C. J. Ngongo, T. J. Raassen, L. Lombard, J van Roosmalen, S. Weyers, and Marleen Temmerman DOI: 10.1111/1471-0528.16047 www.bjog.org Delivery mode for prolonged, obstructed labour resulting in obstetric fistula: a retrospective review of 4396 women in East and Central Africa CJ Ngongo,a TJIP Raassen,b L Lombard,c J van Roosmalen,d,e S Weyers,f M Temmermang,h a RTI International, Seattle, WA, USA b Nairobi, Kenya c Cape Town, South Africa d Athena Institute VU University Amsterdam, Amsterdam, The Netherlands e Leiden University Medical Centre, Leiden, The Netherlands f Department of Obstetrics and Gynaecology, Ghent University Hospital, Ghent, Belgium g Centre of Excellence in Women and Child Health, Aga Khan University, Nairobi, Kenya h Faculty of Medicine and Health Science, Ghent University, Ghent, Belgium Correspondence: CJ Ngongo, RTI International, 119 S Main Street, Suite 220, Seattle, WA 98104, USA. Email: [email protected] Accepted 3 December 2019. Objective To evaluate the mode of delivery and stillbirth rates increase occurred at the expense of assisted vaginal delivery over time among women with obstetric fistula. -
Velvi Product Information Brochure
Vaginal Dilatator www.velvi-vaginismus.com The Velvi Kit is a set of six vaginal dilators, a removable handle and an instructions for use manual. Each Velvi dilator is a purple cylindrical element, smoothly shaped in plastic and specifically adapted to vaginal dilation exercises. Velvi Kit - 6 graduated vaginal dilators Self treatment for painful sexual intercourse : Vaginismus Vulvodynia and dyspareunia Vaginal stenosis vaginal agenesis (MRKH syndrome) After gynecological surgery or trauma following childbirth. Velvi dilators dimensions: Size 1: 4 cm in length with a base diameter of 1 cm. Size 2: 5.5 cm in length with a base diameter of 1.5 cm. Size 3: 7 cm in length with a base diameter of 2 cm. Size 4: 8.5 cm in length with a base diameter of 2.5 cm. Size 5: 10 cm in length with a base diameter of 3 cm. Size 6: 11.5 cm in length with a base diameter of 3.5 cm. The handle can be locked on each dilator Velvi With a simple rotating movement. How to use properly a Velvi dilator ? First, generously lubricate the dilator and the entrance to your vagina. Then gently spread your labia and insert the dilator very slowly inside your vaginal canal. Keep in mind that pushing on your perineum will help you while introducing it. Do not try to guide the dilator, in general it will keep going in the right direction by itself. When starting a new exercise with a dilator, do not immediately try to make any sort of movements. Wait a bit and let some time to your vagina to get used to the fact that a dilator is inserted without moving. -
Self-Care Practices and Immediate Side Effects in Women with Gynecological Cancer
Rev. Enferm. UFSM - REUFSM Santa Maria, RS, v. 11, e35, p. 1-21, 2021 DOI: 10.5902/2179769248119 ISSN 2179 -7692 Artigo Original Submiss ão : 07 /21 /20 20 Aprovação: 03 /18 /202 1 Publicação: 04 /20 /202 1 SelfSelf----carecare practices and immediate side effects in women with gynecological cancer in brachytherapy* Práticas de autocuidado e os efeitos colaterais imediatos em mulheres com câncer ginecológico em braquiterapia Prácticas de autocuidado y los efectos colaterales inmediatos en mujeres con cáncer ginecológico en braquiterapia Rosimeri Helena da Silva III, Luciana Martins da Rosa IIIIII , Mirella Dias IIIIIIIII , Nádia Chiodelli Salum IVIVIV , Ana Inêz Severo Varela VVV, Vera Radünz VIVIVI Abstract : ObjectiveObjective: to reveal the immediate side effects and self-care practices adopted by women with gynecological cancer submitted to brachytherapy. MethodMethod:Method narrative research, conducted with 12 women, in southern Brazil, between December/2018 and January/2019, including semi-structured interviews submitted to content analysis. ResultsResults: three thematic categories emerged from the analysis: Care oriented and adopted by women in pelvic brachytherapy; Immediate side effects perceived by women in pelvic brachytherapy; Care not guided by health professionals. The care provided by the nurses most reported by the women was vaginal dilation, use of a shower and vaginal lubricant, tea consumption, cleaning, and storage of the vaginal dilator. The side effects most frequently mentioned in the interviews were urinary and intestinal changes in the skin and mucous membranes. ConclusionConclusion: nursing care in brachytherapy must prioritize care to prevent and control genitourinary and cutaneous changes, including self-care practices. I Professional Master in Nursing Care Management, Nurse at the Oncological Research Center, Florianópolis, Santa Catarina, Brazil. -
Dyspareunia Treated by Bilateral Pudendal Nerve Block Gregory Amend, Yimei Miao, Felix Cheung, John Fitzgerald, Brian Durkin, S
www.symbiosisonline.org Symbiosis www.symbiosisonlinepublishing.com Case Report SOJ Anesthesiology and Pain Management Open Access Dyspareunia Treated By Bilateral Pudendal Nerve Block Gregory Amend, Yimei Miao, Felix Cheung, John Fitzgerald, Brian Durkin, S. Ali Khan and Srinivas Pentyala* Departments of Urology and Anesthesiology, Stony Brook Medical Center, USA Received: November 19, 2013; Accepted: March 13, 2014, Published: March 14, 2014 *Corresponding author: Srinivas Pentyala, Department of Anesthesiology, Stony Brook Medical Center, Stony Brook, NY 11794-8480, New York, USA; Tel: 631-444-2974; Fax: 631-444-2907; E-mail: [email protected] patient’s last sexual attempt was 2 weeks prior to presentation. Abstract The patient was in a stable long term marriage with no history of physical, sexual, or emotional abuse. Patient denied use of alcohol, dyspareunia of unclear etiology, who was successfully managed with tobacco, and illicit drugs. There was no history of psychiatric In this report, we present a patient with refractory superficial a bilateral pudendal nerve block. Initial workup failed to identify conditions, endocrine abnormalities, neurologic illnesses, pelvic trauma, sexually transmitted infections, incontinence, pudendalan obvious nerve source block for alleviated the pain the and problem first-line to threetherapy years for follow- post- up.menopausal In this report, superficial we review dyspareunia the current was dyspareunia not effective. literature A bilateral and vaginal stenosis. The patient previously had multiple abdominal propose a diagnostic algorithm. incisions,pelvic floor including disorders, two electiveurological C-sections problems, and endometriosis, a total abdominal or Keywords: Dyspareunia; Organ prolapse; Vaginitis; Pudendal nerve hysterectomy for dysfunctional uterine bleeding 4 years prior block; Vulvar vestibulitis to presentation. -
A Guide to Obstetrical Coding Production of This Document Is Made Possible by Financial Contributions from Health Canada and Provincial and Territorial Governments
ICD-10-CA | CCI A Guide to Obstetrical Coding Production of this document is made possible by financial contributions from Health Canada and provincial and territorial governments. The views expressed herein do not necessarily represent the views of Health Canada or any provincial or territorial government. Unless otherwise indicated, this product uses data provided by Canada’s provinces and territories. All rights reserved. The contents of this publication may be reproduced unaltered, in whole or in part and by any means, solely for non-commercial purposes, provided that the Canadian Institute for Health Information is properly and fully acknowledged as the copyright owner. Any reproduction or use of this publication or its contents for any commercial purpose requires the prior written authorization of the Canadian Institute for Health Information. Reproduction or use that suggests endorsement by, or affiliation with, the Canadian Institute for Health Information is prohibited. For permission or information, please contact CIHI: Canadian Institute for Health Information 495 Richmond Road, Suite 600 Ottawa, Ontario K2A 4H6 Phone: 613-241-7860 Fax: 613-241-8120 www.cihi.ca [email protected] © 2018 Canadian Institute for Health Information Cette publication est aussi disponible en français sous le titre Guide de codification des données en obstétrique. Table of contents About CIHI ................................................................................................................................. 6 Chapter 1: Introduction .............................................................................................................. -
Experiences of Women with Obstetric Fistula in Nigeria: a Narrative Inquiry
THE UNIVERSITY OF HULL Experiences of Women with Obstetric Fistula in Nigeria: A Narrative Inquiry A Thesis Submitted to the University of Hull in Fulfilment of the Award of Degree of Doctor of Philosophy in Health Studies By Hannah Mafo Degge MPH (2011) University of Leeds, UK April 2018 DEDICATION In loving memories of my beloved husband, Abraham Degge (who believed in me and set me on the path to doing a PhD) and my beloved son Boyesoko Degge (too wonderful a son to be forgotten) And to the brave women, who shared their stories- “A voice to make maternal healthcare accessible to all” ii ACKNOWLEDGEMENT The PhD journey has been a long and hard journey that would have been impossible to achieve without the kindness, support and encouragement of numerous people. First and foremost, I sincerely and deeply appreciate my supervisors, Prof Mark Hayter and Dr Mary Laurenson, for their thorough and relentless guidance, support and encouragement all through the study process. I acknowledge with deep gratitude Dr Moira Graham, Research Director, Faculty of Health Sciences for your ceaseless words of encouragement and support. I wish to also acknowledge the support of EVVF centre, BHUTH, and particularly the director, Dr Sunday Lengmang for the encouragement and sustained motivation to do this research. My parents Chief and Mrs. Andrew Aileku OFR, my brothers and sisters and their families, who stood solidly behind me in this journey. I sincerely appreciate your prayers, support and encouragement, that kept me moving on throughout the study period. My PhD colleagues who became like a family to me, too numerous to mention, I appreciate the support and encouragements of Sheena McRae, Love Onuorah, Yetunde Atayeiro, Franklin Onwukgha, and Peninah Agaba, challenging me to keep moving forward. -
Chapter 9 Risk Factors
Chapter 9 Risk factors 9.1 Introduction The previous chapters have all focused on adverse pregnancy and birth outcomes as risk factors for foetal loss and neonatal death. The present chapter takes the discussion and analysis one layer further to the underlying risk factors for the selected adverse pregnancy and birth outcomes themselves. These risk factors are more remote in the causal chain and include maternal factors, complications of the placenta, cord, and membranes, and birth complications. These have been referred to earlier, in Chapter 3, in the operationalisation of the conceptual model (Figure 3.6). Besides their direct effect on pregnancy/birth outcome, they are believed to affect foetal loss (i.e. spontaneous abortion and stillbirth), both directly and indirectly, and neonatal death indirectly through the intermediate outcomes (i.e. adverse pregnancy and birth outcomes). As became clear in Chapter 3, many different causes and risk factors underlie the adverse pregnancy and birth outcomes, but what appear to be main risk factors? Are these risk factors also important in regions in transition and, more specifically, in Kerala? Moreover, does the relative importance of these risk factors change during the epidemiologic transition? A region’s position within the transition could very well be reflected by its specific combination of underlying risk factors. Factors such as infections and malnutrition are likely to be important during the early of the transition, while others such as diabetes and advanced maternal age may become more significant during later stages. This could lead to a redefinition of the concepts of endogenous and exogenous mortality (see Chapter 2). -
Contemporary Issues in Obstetric Fistula
CLINICAL OBSTETRICS AND GYNECOLOGY Volume 00, Number 00, 000–000 Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved. Contemporary Issues in Obstetric Fistula L. LEWIS WALL, MD, DPHIL,*† ITENGRE OUEDRAOGO, MD,‡ and FEKADE AYENACHEW, MD§ *Department of Anthropology, College of Arts and Sciences; †Department of Obstetrics and Gynecology, School of Medicine, Washington University in St. Louis, St. Louis, Missouri; ‡Association Renaissance Arena, Ouagadougou, Burkina Faso; Danja Fistula Center, Danja, Niger; and §International Fistula Alliance, Terrewode Women’s Community Hospital, Soroti, Uganda Abstract: We discuss a variety of contemporary issues connected: for example, a vesicovaginal relating to obstetric fistula. These include definitions of fistula is an abnormal opening between these injuries, the etiologic mechanisms by which fistulas occur, the role of specialist fistula centers in diagnosis the bladder and the vagina. and management, the classification of fistulas, and the Fistulas arise in different ways. A small assessment of surgical outcomes. We also review the number of fistulas are congenital, arising growing need for complex reconstructive surgical pro- from defects that occur during embryog- cedures, follow-up challenges, and the transition to a enesis.1 More commonly, however, fistu- fistula-free world in which other pathologies (such as 2,3 pelvic organ prolapse) will be of increasing importance. las are caused by trauma. Finally, we discuss the need to develop responsive The most common fistulas occurring in systems of maternal health care that treat women with females are genitourinary fistulas (vesico- competence, compassion, respect, and fairness. vaginal fistula, urethrovaginal fistula, Key words: obstetric fistula, vesicovaginal fistula, ’ ureterovaginal fistula, etc.) and genito- obstructed labor, women s rights enteric fistulas (especially rectovaginal fistula). -
Obstetric Fistula Guiding Principles for Clinical Management and Programme Development
Obstetric Fistula Guiding principles for clinical management and programme development Making Pregnancy Safer World Health Organization Contents Akcnowledgement iii Preface v Section I vii 1 Introduction 1 2 Principles for the development of a national or sub- national strategy for the protection and treatment 7 Annex A: Recommendationss on training from the Niamey meeting 22 Annex B: Recommendations on monitoring and evaluation of programmes from the Niamey meeting (2005) 25 Section II 27 3 Clinical and surgical principles for the management and repair of obstetric fi stula 29 Annex C: The classifi cation of obstetric fi stula 37 4 Principles of nursing care 39 Annex D: Patient card 45 5 Principles for pre and post operative physiotherapy 47 6 Principles for hte social reintegration and rehabilitation of women wh have had an obstetric fi stula repair 53 III Acknowledgments Editors: Gwyneth Lewis, Luc de Bernis, Fistula Manual Steering Committee established by the International Fistula working group: Andre De Clercq, Charlotte Gardiner, Ogbaselassie Gebream- lak, Jonathan Kashima, John Kelly, Ruth Kennedy, Barbara E. Kwast, Peju Olukoya, Doyin Oluwole, Naren Patel, Joseph Ruminjo, Petra Ten Hoope, We are grateful to the following people for their advice and help with specifi c chapters of this manual: Chapter 1: Glen Mola, Charles Vangeenderhuysen Chapter 2: Maggie Bangser, Adrian Brown, Yvonne Wettstein Chapter 3: Fistula Surgeons: Andrew Browning, Ludovic Falandry, John Kelly, Tom Raassen, Kees Waaldijk, Ann Ward, Charles-Henry Rochat, Baye Assane Diagne, Shershah Syed, Michael Breen, Lucien Djangnikpo, Brian Hancock, Abdulrasheed Yusuf, Ouattara Chapter 4: Ruth Kennedy Chapter 5: Lesley Cochrane Chapter 6: Maggie Bangser, Yvonne Wettstein Additional thanks are due to: France Donnay, Kate Ramsey, Claude Dumurgier, Rita Kabra, Zafarullah Gill. -
Prevalence & Factors Associated with Chronic Obstetric Morbidities In
Indian J Med Res 142, October 2015, pp 479-488 DOI:10.4103/0971-5916.169219 Prevalence & factors associated with chronic obstetric morbidities in Nashik district, Maharashtra, India Sanjay Chauhan, Ragini Kulkarni & Dinesh Agarwal* Department of Operational Research, National Institute for Research in Reproductive Health (ICMR), Mumbai & *United Nations Population Fund, New Delhi, India Received February 20, 2014 Background & objectives: In India, community based data on chronic obstetric morbidities (COM) are scanty and largely derived from hospital records. The main aim of the study was to assess the community based prevalence and the factors associated with the defined COM - obstetric fistula, genital prolapse, chronic pelvic inflammatory disease (PID) and secondary infertility among women in Nashik district of Maharashtra State, India. Methods: The study was cross-sectional with self-reports followed by clinical and gynaecological examination. Six primary health centre areas in Nashik district were selected by systematic random sampling. Six months were spent on rapport development with the community following which household interviews were conducted among 1560 women and they were mobilized to attend health facility for clinical examination. Results: Of the 1560 women interviewed at household level, 1167 women volunteered to undergo clinical examination giving a response rate of 75 per cent. The prevalence of defined COM among 1167 women was genital prolapse (7.1%), chronic PID (2.5%), secondary infertility (1.7%) and fistula (0.08%). Advancing age, illiteracy, high parity, conduction of deliveries by traditional birth attendants (TBAs) and obesity were significantly associated with the occurrence of genital prolapse. History of at least one abortion was significantly associated with secondary infertility. -
Original Article
ORIGINAL ARTICLE MOIST VAGINAL PACKING FOR UTERO-VAGINAL PROLAPSE-A CLINICAL STUDY Manidip Pal, Soma Bandyopadhyay 1. Associate Professor, Department of Obestetrics & Gynaecology, College of Medicine & JNM Hospital, WBUHS, Kalyani, Nadia, West Bengal. 2. Associate Professor, Department of Obestetrics & Gynaecology, Jawaharlal Nehru Institute of Medical Sciences, Porompat, Imphal, Manipur. CORRESPONDING AUTHOR Manidip Pal, Associate Professor, OBGYN, College of Medicine & JNM Hospital, WBUHS, Kalyani, Nadia, West Bengal, PIN –741235. E-mail: [email protected] Ph: 0091 9051678490 ABSTRACT: BACKGROUND : Utero-vaginal prolapse is a common condition in aged women and often they come to us with decubitus ulcer. Prolonged vaginal packing not only will heal the decubitus ulcer but also it may help in returning the normal rugosity of the vaginal skin. AIMS: To assess the role of prolonged moist vaginal packing in utero-vaginal prolpase. SETTINGS & DESIGN: It was an OPD based prospective study conducted at the gynecology OPD of College of Medicine & JNM Hospital, WBUHS, Kalyani, Nadia, West Bengal and Jawaharlal Nehru Institute of Medical Sciences, Porompat, Imphal, Manipur. METHODS & MATERIAL: Hundred (100) patients of utero-vaginal prolapse with decubitus ulcer were studied. After initial staging (POP- Q staging), daily moist (5% povidone-iodine solution soaked gauze) vaginal packing at home was advised. After 2 weeks, re-examination done for decubitus ulcer healing. Packing continued till operation (interval 1- 1½ month). Preoperative staging and modification of operation were noted. On follow up complication (mainly recurrence) was noted. RESULTS: Initial staging was stage 3 - 39%, stage 4 - 61%. Preoperative scoring revealed stage 3 became stage 2 in 54% cases and stage 4 became stage 3 in 49% cases.